Contrast Media & Medical Devices

Contrast Media

Lipiodol® Ultra Fluid
Iodinated ethyl esters of fatty acids of poppyseed oil

Discovered by Marcel Guerbet in 1901, Lipiodol® Ultra Fluid was the first iodinated contrast agent used in the world. It was first used in radiology in France in 1921.

Since 1980, Lipiodol® Ultra Fluid is developed in interventional radiology. 

It is currently available in 47 countries.

Patent Blue V
Patent Blue V sodium salt

Patent Blue V, which is not a contrast agent but rather a dye, was launched on the Belgian market in 1971.

To top

Medical Devices

Vectorio®

Vectorio® is a mixing and injection system for Conventional Trans-Arterial Chemo-Embolization (cTACE).

Vectorio® is a set of Lipiodol Ultra Fluid resistant medical devices including syringes, patented stopcock and withdrawing devices.

SeQure® and DraKon™ microcatheters

SeQure® and DraKon™ are microcatheters for peripheral vessels embolization.

They are intended for:

  • Infusion of contrast media into all peripheral vessels;
  • Drug infusion in intra-arterial therapy;
  • Infusion of embolic materials. 

SeQure® and Drakon™ microcatheters should not be used in cerebral vessels.

SeQure® is an innovative reflux control microcatheter that uses flow dynamics to create a fluid barrier.

DraKon™ is a standard microcatheter adapted for any peripheral embolizations (including cTACE).

SeQure® and DraKon™ are authorized for commercialization in the United States and in Europe. They are also registered in Hong Kong, in New Zealand and in Thailand.

To top